Drugs & TargetsFree Keytruda receives second biomarker-based indication from FDA, regardless of tumor type June 19, 2020Vol.46 No.25
Drugs & TargetsFree FoundationOne CDx receives FDA approval as companion diagnostic with Keytruda June 19, 2020Vol.46 No.25
Drugs & TargetsFree Lurbinectedin receives accelerated approval by FDA for metastatic SCLC June 19, 2020Vol.46 No.25
Drugs & TargetsFree Gemtuzumab ozogamicin receives extended indication for CD33-positive AML in pediatric patients June 19, 2020Vol.46 No.25
Drugs & TargetsFree City of Hope signs licensing agreement with Scopus BioPharma to develop novel, targeted IO gene therapy June 19, 2020Vol.46 No.25
Drugs & TargetsFree Royal Philips and MD Anderson to facilitate personalized oncology treatments and clinical trial matching based on genomic markers June 19, 2020Vol.46 No.25
Drugs & TargetsFree Isoray, University of Cincinnati physicians company sign research agreement to study head and neck cancers June 19, 2020Vol.46 No.25
Clinical RoundupFree LLS, NCI and Children’s Oncology Group collaborate on global master clinical trial for acute leukemia June 19, 2020Vol.46 No.25
Clinical RoundupFree Research and framework for genetic testing in prostate cancer supports broader use of panels, testing in early stage disease June 19, 2020Vol.46 No.25
